United Therapeutics Corporation (UTHR) DCF Valuation

United Therapeutics Corporation (UTHR) DCF Valuation
  • ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
  • ✓ Design Profissional: Modelos Confiáveis ​​E Padrão Da Indústria
  • ✓ Pré-Construídos Para Uso Rápido E Eficiente
  • ✓ Não É Necessária Experiência; Fácil De Seguir

United Therapeutics Corporation (UTHR) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

As an investor or analyst, this [Symbol] (UTHR) DCF Calculator is the perfect resource for accurate valuation. Loaded with real data from United Therapeutics Corporation, you can easily adjust forecasts and observe the effects in real time.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 1,448.8 1,483.3 1,685.5 1,936.3 2,327.5 2,624.8 2,960.1 3,338.2 3,764.7 4,245.6
Revenue Growth, % 0 2.38 13.63 14.88 20.2 12.77 12.77 12.77 12.77 12.77
EBITDA -74.9 646.3 736.8 1,040.3 1,386.8 1,025.9 1,157.0 1,304.8 1,471.4 1,659.4
EBITDA, % -5.17 43.57 43.71 53.73 59.58 39.09 39.09 39.09 39.09 39.09
Depreciation 45.9 49.9 49.9 51.3 53.2 75.7 85.4 96.3 108.6 122.5
Depreciation, % 3.17 3.36 2.96 2.65 2.29 2.89 2.89 2.89 2.89 2.89
EBIT -120.8 596.4 686.9 989.0 1,333.6 950.2 1,071.5 1,208.4 1,362.8 1,536.9
EBIT, % -8.34 40.21 40.75 51.08 57.3 36.2 36.2 36.2 36.2 36.2
Total Cash 2,253.4 2,984.6 3,580.6 4,154.9 2,994.1 2,624.8 2,960.1 3,338.2 3,764.7 4,245.6
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 151.4 157.4 198.7 220.4 278.9
Account Receivables, % 10.45 10.61 11.79 11.38 11.98
Inventories 93.4 86.5 93.8 102.0 111.8 146.5 165.3 186.4 210.2 237.0
Inventories, % 6.45 5.83 5.57 5.27 4.8 5.58 5.58 5.58 5.58 5.58
Accounts Payable 9.9 4.1 3.8 4.1 5.6 8.6 9.7 10.9 12.3 13.9
Accounts Payable, % 0.68332 0.27641 0.22545 0.21174 0.2406 0.32751 0.32751 0.32751 0.32751 0.32751
Capital Expenditure -83.7 -59.3 -120.8 -138.8 -230.4 -178.5 -201.3 -227.1 -256.1 -288.8
Capital Expenditure, % -5.78 -4 -7.17 -7.17 -9.9 -6.8 -6.8 -6.8 -6.8 -6.8
Tax Rate, % 22.72 22.72 22.72 22.72 22.72 22.72 22.72 22.72 22.72 22.72
EBITAT -76.5 480.6 550.3 756.7 1,030.6 718.0 809.7 913.1 1,029.8 1,161.3
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -349.2 466.3 430.5 639.6 786.6 567.2 638.4 720.0 812.0 915.7
WACC, % 7.03 7.09 7.09 7.07 7.08 7.07 7.07 7.07 7.07 7.07
PV UFCF
SUM PV UFCF 2,941.7
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 934
Terminal Value 18,416
Present Terminal Value 13,087
Enterprise Value 16,028
Net Debt -508
Equity Value 16,536
Diluted Shares Outstanding, MM 50
Equity Value Per Share 332.72

What You Will Receive

  • Adjustable Forecast Variables: Modify key assumptions (growth %, profit margins, discount rate) to explore various scenarios.
  • Comprehensive Data: United Therapeutics Corporation’s financial information pre-loaded to facilitate your analysis.
  • Instant DCF Calculations: The template automatically computes Net Present Value (NPV) and intrinsic value for you.
  • Tailored and Professional Design: A refined Excel model that meets your specific valuation requirements.
  • Designed for Analysts and Investors: Perfect for evaluating forecasts, confirming strategies, and enhancing efficiency.

Key Features

  • Real-Life UTHR Data: Pre-filled with United Therapeutics Corporation’s historical financials and future projections.
  • Fully Customizable Inputs: Modify revenue growth, profit margins, WACC, tax rates, and capital expenditures as needed.
  • Dynamic Valuation Model: Instant updates to Net Present Value (NPV) and intrinsic value based on your adjustments.
  • Scenario Testing: Develop various forecast scenarios to evaluate different valuation results.
  • User-Friendly Design: Intuitive, organized, and tailored for both professionals and newcomers.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review United Therapeutics Corporation’s (UTHR) pre-filled financial data and forecasts.
  3. Step 3: Modify critical inputs like revenue growth, WACC, and tax rates (highlighted cells).
  4. Step 4: Watch the DCF model update instantly as you tweak assumptions.
  5. Step 5: Analyze the outputs and use the results for investment decisions.

Why Choose This Calculator for United Therapeutics Corporation (UTHR)?

  • Accuracy: Utilizes real United Therapeutics financial data for precise calculations.
  • Flexibility: Allows users to easily adjust and test various inputs.
  • Time-Saving: Avoid the complexity of creating a DCF model from the ground up.
  • Professional-Grade: Crafted with the precision and usability expected at the CFO level.
  • User-Friendly: Intuitive design makes it accessible for users without extensive financial modeling skills.

Who Should Use This Product?

  • Investors: Evaluate United Therapeutics Corporation’s (UTHR) fair value to inform investment choices.
  • CFOs: Utilize a high-quality DCF model for accurate financial reporting and analysis.
  • Consultants: Easily modify the template for client valuation reports specific to United Therapeutics Corporation (UTHR).
  • Entrepreneurs: Discover financial modeling techniques employed by leading biotech firms.
  • Educators: Implement it as an educational resource to illustrate valuation strategies.

What the Template Contains

  • Pre-Filled DCF Model: United Therapeutics Corporation’s (UTHR) financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
  • Financial Ratios: Evaluate United Therapeutics Corporation’s (UTHR) profitability, leverage, and efficiency.
  • Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
  • Financial Statements: Annual and quarterly reports to support detailed analysis.
  • Interactive Dashboard: Easily visualize key valuation metrics and results.

No products were found matching.